Workflow for the generation of SARS-CoV-2-derived HLA I and HLA II immunopeptidome data. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-51959-6 Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader immunity than existing vaccinations. In a paper published in the journal Nature...
Category: <span>Vaccines</span>
Post
New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in Canadian Medical Association Journal. “Our results have important policy implications in Canada, and in other similar high-income countries evaluating whether to switch to 1-dose HPV vaccination,” writes Dr. Marc Brisson, a full professor at...
Post
Influenza vaccine protects children from infection and hospitalization for the disease, Spanish study shows
An article published in Eurosurveillance has demonstrated that Spain’s influenza vaccination campaign for children aged 6–59 months during the 2023/24 season was effective in preventing acute respiratory infections (ARI) and hospitalization, as vaccination was recommended for this age group at the national level for the first time. In the context of Child Health Day 2024, this research emphasizes that...
Post
This season’s flu vaccine cuts risk of hospitalization by almost 35%, finds report
The Southern Hemisphere’s flu season is winding down, and new data shows this year’s flu shot was 34.5% effective in keeping folks there who got influenza from needing hospital care. Most (68.3%) of those sent to hospital had the A(H3N2) strain of flu, according to the report from the U.S. Centers for Disease Control and...
Post
Study demonstrates that mpox vaccine antibody responses wane within a year
Mpox Virus Particle Colorized transmission electron micrograph of an mpox virus particle (yellow and red) found within an infected VERO E6 cell (blue), cultured in the laboratory. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID/CC0 Public Domain A study led by researchers at Beth Israel Deaconess Medical Center...